Price $4.23 |
Market Cap
173.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.62
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-33.6K
|
FCF
-0.9
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-46.90%
|
ROI
-
|
|
ROA
-44.30%
|
EPS Growth
40.10%
|
Current Ratio
11.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Sellas Life Sciences Group Inc (SLS) | $5.27 | - | - | 35.9M | Strong Buy |
| Community Health Systems (CYH) | $4.38 | - | - | 453.6M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.28 | - | - | 13.1M | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $9.10 | - | - | 111.9M | Strong Buy |
| Milestone Scientific Inc. (MLSS) | $0.91 | - | - | 25.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
